PARP inhibitors as a radiosensitizer: a future promising approach in prostate cancer?
{{output}}
Poly (ADP-ribose) polymerase (PARP) inhibitors (iPARPs) have shown efficacy in homologous recombination (HR) deficiency patients with advanced castration resistant prostate cancer and have shown a radiosensitizing effect in preclinical and early clinical trial... ...